BARRANCO, MARÍA MANUELA; ZECCHINATI, FELIPE; PERDOMO, VIRGINIA GABRIELA; HABIB, MARTÍN JOSÉ; RICO, MARÍA JOSÉ; ROZADOS, VIVIANA ROSA; SALAZAR, MARIO; FUSINI, MATÍAS EZEQUIEL; SCHAROVSKY, OLGA GRACIELA; VILLANUEVA, SILVINA STELLA MARIS; MAINETTI, LEANDRO ERNESTO; GARCÍA, FABIANA

Intestinal ABC transporters: Influence on the metronomic cyclophosphamide-induced toxic effect in an obese mouse mammary cancer model

TOXICOLOGY AND APPLIED PHARMACOLOGY; Año: 2024 vol. 492

MAINETTI LE; RICO MJ; KAUFMAN CD; GRILLO MC; GUERCETTI J; BAGLIONI MV; DEL GIÚDICE A; CAPITANI MC; FUSINI ME; ROZADOS VR; SCHAROVSKY OG

Losartan improves the therapeutic effect of metronomic cyclophosphamide in triple negative mammary cancer models

Oncotarget; Lugar: Orchard Park, NY 14127; Año: 2020

SCHAROVSKY, O. GRACIELA; RICO, MARÍA JOSÉ; MAINETTI, LEANDRO E.; PERROUD, HERMAN A.; ROZADOS, VIVIANA R.

Achievements and challenges in the use of metronomics for the treatment of breast cancer

BIOCHEMICAL PHARMACOLOGY; Año: 2020 vol. 175

GIOLITO, MARÍA V; CAMACHO, CRISTIAN M; MARTINEZ-AMEZAGA, MAITENA; TRAFICANTE, CARLA I; GIORDANO, ROCÍO A; CORNIER, PATRICIA G; MATA, ERNESTO G; DELPICCOLO, CARINA ML; BOGGIÁN, DORA B; GIÚDICE, ANTONELA DEL; MAINETTI, LEANDRO E; SCHAROVSKY, OLGA G; ROZADOS, VIVIANA R; RICO, MARÍA J

Antitumor activity of new chemical compounds in triple negative mammary adenocarcinoma models

Future Science OA; Lugar: Londres; Año: 2020 vol. 6

GIÚDICE, ANTONELA DEL; PAGURA, LUCAS; CAPITANI, MARIÁ CELESTE; MAINETTI, LEANDRO ERNESTO; SCHAROVSKY, O. GRACIELA; DI MASSO, RICARDO JOSÉ; RICO, MARIÁ JOSÉ; ROZADOS, VIVIANA ROSA

Nonclassical roles for IFN-γand IL-10 in a murine model of immunoedition

Future Science OA; Año: 2020 vol. 6

PERROUD, HERMAN ANDRES; ALASINO, CARLOS MARIA; RICO, MARIA JOSE; MAINETTI, LEANDRO ERNESTO; QUERALT, FRANCISCO; PEZZOTTO, STELLA MARIS; ROZADOS, VIVIANA ROSA; GRACIELA SCHAROVSKY, O.

Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: Clinical outcomes and biomarkers of response

CANCER CHEMOTHERAPY AND PHARMACOLOGY; Año: 2016 vol. 77 p. 365 - 374

CHO, WON JIN; OLIVEIRA, DANIEL S.M.; NAJY, ABDO J.; MAINETTI, LEANDRO E.; AOUN, HUSSEIN D.; CHER, MICHAEL L.; HEATH, ELISABETH; KIM, HYEONG-REH C.; BONFIL, R. DANIEL

Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients

JOURNAL OF TRANSLATIONAL MEDICINE; Año: 2016 vol. 14

ROSÉ, ADRIANA; ANDRÉ, NICOLAS; ROZADOS, VIVIANA R.; MAINETTI, LEANDRO E.; MÁRQUEZ, MAURICIO MENACHO; RICO, MARÍA JOSÉ; SCHAIQUEVICH, PAULA; VILLARROEL, MILENA; GREGIANIN, LAURO; GRAUPERA, JAUME MORA; GARCÍA, WENDY GÓMEZ; EPELMAN, SIDNEI; ALASINO, CARLOS; ALONSO, DANIEL; CHANTADA, GUILLERMO; SCHAROVSKY, O. GRACIELA

Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27-28 May, 2016, Rosario, Argentina

ecancermedicalscience; Año: 2016 vol. 10

RICO MJ; PERROUD HA; MAINETTI LE; ROZADOS VR; SCHAROVSKY OG

Comparative effectiveness of two metronomic chemotherapy schedules. Our experience in the preclinical field

CANCER INVESTIGATION; Lugar: Londres; Año: 2014 vol. 32 p. 92 - 98

MAINETTI LE ; ZHE X; DIEDRICH J; SALIGANAN AD; CHO WJ; CHER M; HEATH E; FRIDMAN R; KIM H; BONFIL, RD

Bone-induced c-kit expression in prostate cancer: a driver of intraosseous tumor growth.

INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Lugar: New York; Año: 2014

MAINETTI LE ; RICO MJ; FERNÁNDEZ ZENOBI MV; PERROUD HA; ROGGERO EA; ROZADOS VR; SCHAROVSKY OG

Therapeutic efficacy of metronomic chemotherapy with cyclophosphamide and doxorubicin on murine mammary adenocarcinomas

ANNALS OF ONCOLOGY; Lugar: Oxford; Año: 2013 vol. 24 p. 2310 - 2316

4. PERROUD HA, RICO MJ, ALASINO CM, QUERALT F, MAINETTI LE, PEZZOTTO SM, ROZADOS VR, SCHAROVSKY OG

SAFETY AND THERAPEUTIC EFFECT OF METRONOMIC CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE AND CELECOXIB IN ADVANCED BREAST CANCER PATIENTS

FUTURE ONCOLOGY; Lugar: Londres; Año: 2013

6. SCHAROVSKY OG, MATAR P, ROZADOS VR, RICO MJ, ZACARÍAS FLUCK MF, MAINETTI LE, FERNÁNDEZ ZENÓBI MV, ROGGERO EA, GERVASONI SI, ROSSA A, PERROUD HA, SÁNCHEZ AM, CELORIA GC, FONT MT

Inmunomodulación y antiangiogénesis en la terapéutica oncológica. De la investigación básica a la clínica.

MEDICINA (BUENOS AIRES); Lugar: Buenos Aires; Año: 2012 vol. 72 p. 47 - 57

RICO MJ, ROZADOS VR, MATAR P, MAINETTI LE, ZACARíAS-FLUCK MF, SCHAROVSKY OG

Regulatory T cells but not NKT I cells are modulated by a single low-dose Cyclophosphamide in a B cell lymphoma tumor-model

Experimental Oncology; Año: 2012 vol. 34 p. 38 - 42

MAINETTI LE, ROZADOS VR, ROSSA A, BONFIL RD, SCHAROVSKY OG

Antitumoral and antimetastatic effects of metronomic chemotherapy with cyclophosphamide and celecoxib on murine mammary adenocarcinomas.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; Lugar: New York; Año: 2011 vol. 137 p. 151 - 163

ROZADOS VR, MAINETTI LE, RICO MJ, ZACARÍAS FLUCK MF, MATAR P, SCHAROVSKY OG

The immune response and the therapeutic effect of metronomic chemotherapy with cyclophosphamide.

ONCOLOGY RESEARCH; Lugar: New York; Año: 2010 vol. 18 p. 601 - 605

SCHAROVSKY OG; MAINETTI LEANDRO E; ROZADOS VR

• Metronomic chemotherapy changing the paradigm that more is better

current oncology; Lugar: Toronto; Año: 2009 vol. 16 p. 7 - 15